Showing 781-790 of 2796 results for "".
Lewy Body Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/lewy-body-dementia-1/31536/The second highest cause of dementia is highly variable.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.Neuromyelitis Optica Spectrum Disorders
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuromyelitis-optica-spectrum-disorders/30129/It is critical to maintain a high index of suspicion for these conditions when evaluating a patient with demyelination to avoid delays in treatment.Poststroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/poststroke-care/30147/Stroke outcomes can be optimized with an evidenced-based and systematic approach during all phases of recovery.Sleep & Neurodegenerative Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/sleep--neurodegenerative-disease/30108/Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.Multiple Sclerosis Treatment in Racial and Ethnic Minorities
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-treatment-in-racial-and-ethnic-minorities/31634/Systematic literature review shows little evidence to guide treatment.The Whole Physician: Physicians with Substance Use Disorder: Help Is Available
https://practicalneurology.com/columns/practice-management/the-whole-physician-physicians-with-substance-use-disorder-help-is-available/32059/Support is available for physicians with substance use disorder, allowing them to return to health and their profession.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Sexual Discomfort: Dealing with Dysfunction in MS and Other Neurological Conditions
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0509_01-php/30915/Sexual dysfunction can be detrimental to patients with neurodegenerative disease—especially MS. So why aren't patients—and neurologists—talking more about it?